TAT GIDA SANAYİ A.Ş.

Capital/Financing Update • Jan 16, 2025

Summary Info	Board of Directors' Decision on authorization for domestic debt instrument issuance
Update Notification Flag	No
Correction Notification Flag	No
Postponed Notification Flag	No

Authorized Member Decision Date	16.01.2025
Issue Limit	2.000.000.000
Currency Unit	TRY
Issue Limit Security Type	Debt Securities
Sale Type	Private Placement-Sale To Qualified Investor
Domestic / Oversea	Domestic

Additional Explanations

Based on the authority granted by our Board of Directors in Article 8 of our Company's Articles of Association on 16.01.2025, it has been decided to authorize the Company's management to conduct debt instrument issuance transactions in Turkish Lira up to a total of 2 Billion Turkish Lira in various arrangements and maturities, in accordance with the provisions of the Debt Instruments Communiqué of the Capital Markets Board, without a public offering in the country, by way of private placement and/or sale to qualified investors and in a manner that will not lead to a public offering, to be traded on the relevant market of Borsa Istanbul A.Ş., within a period of 1 year, in accordance with the principles to be determined depending on the market conditions. The necessary permit application will be made to the Capital Markets Board within the scope of this decision. This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.